KANOVSKY STEPHEN M 4

What Happened

• Stephen M. Kanovsky, a director of NeoGenomics Inc. (NEO), exercised/converted a derivative and had restricted stock units (RSUs) released on 2026-06-01. The filing shows acquisition of 23,077 shares via exercise/conversion (exercise price $0.00) and the release/grant-acquisition of 11,069 and 15,970 shares (both derivative/RSU-related). There is also a corresponding reported disposition of 23,077 derivative shares at $0.00. In total the filing records 50,116 shares acquired and 23,077 derivative shares disposed, a net increase of 27,039 shares for the insider per this report. The filing lists $0.00 as the price on these transactions, so no cash payment is shown.

Key Details

• Transaction date: 2026-06-01 (reported on Form 4 filed 2026-06-03)
• Recorded transactions:
  • Exercise/conversion (M): 23,077 shares acquired @ $0.00
  • Exercise/conversion (M): 23,077 shares disposed @ $0.00 (derivative)
  • Grant/award release (A): 11,069 shares acquired @ $0.00 (derivative; RSU release)
  • Grant/award release (A): 15,970 shares acquired @ $0.00 (derivative; RSU release)
• Net change reported on this Form 4: +27,039 shares (50,116 acquired minus 23,077 disposed)
• Shares owned after the transactions: not stated in the provided filing summary
• Footnotes in the filing:
  • F1: The reported acquisitions reflect the release of restricted stock units previously reported on a Form 4.
  • F2: Once vested, the released shares of common stock are not subject to expiration.
• Filing timeliness: Form 4 filed 2 days after the transaction date (appears timely, not marked late)

Context

• Derivative explanation: The filing shows an exercise/conversion of a derivative instrument and the release of RSUs. When a derivative is exercised or RSUs vest, shares are typically issued to the insider; the $0.00 exercise/price here means the filing shows no cash paid for those reported shares. The separate disposition entry at $0.00 likely reflects an internal conversion/settlement reporting detail rather than an open-market sale for cash.
• For retail investors: awards and RSU releases are common forms of compensation and do not necessarily signal a buy/sell decision; purchases are generally more informative about insider sentiment. This report documents compensation-related issuance and a net increase in the director’s holdings per the filing.